UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 23, 2004
NANOPHASE TECHNOLOGIES CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 36-3687863 | |
| (State of incorporation) | (I.R.S Employer Identification No.) |
1319 Marquette Drive
Romeoville, Illinois 60446
(630) 323-1200
(Address, including zip code, and telephone number, including
area code, of registrant’s principal executive offices)
| Item 5. | Other Events and Required FD Disclosure |
On March 23, 2004 the Company entered into a Joint Development Agreement with Altana Chemie AG. In connection with the agreement, the Company issued 1,256,281 shares of its common stock to Altana Chemie AG at a purchase price of $7.96 per share for an aggregate consideration of $10,000,000. On March 25, 2004, the Company issued a Press Release disclosing such transactions with Altana Chemie AG. A copy of the Press Release is being filed as Exhibit 99.1 and is incorporated herein by reference.
| Item 7. | Financial Statements and Exhibits |
| (c) | Exhibits |
| 99.1 | Press Release dated March 25, 2004 |
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Nanophase Technologies Corporation | ||
| By | /s/ Joseph Cross | |
Joseph Cross, Chief Executive Officer | ||
Date: March 25, 2004